| 000 | 01714 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516062652.0 | ||
| 264 | 0 | _c20120423 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1098-1004 | ||
| 024 | 7 |
_a10.1002/humu.21636 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFoldynova-Trantirkova, Silvie | |
| 245 | 0 | 0 |
_aSixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. _h[electronic resource] |
| 260 |
_bHuman mutation _cJan 2012 |
||
| 300 |
_a29-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBone and Bones _xabnormalities |
| 650 | 0 | 4 |
_aCartilage _xabnormalities |
| 650 | 0 | 4 | _aCell Communication |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aChondrocytes _xmetabolism |
| 650 | 0 | 4 |
_aFibroblast Growth Factors _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenes, Lethal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNatriuretic Peptide, C-Type _xgenetics |
| 650 | 0 | 4 |
_aOsteochondrodysplasias _xgenetics |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 3 _xgenetics |
| 650 | 0 | 4 |
_aSTAT1 Transcription Factor _xgenetics |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSkin _xmetabolism |
| 650 | 0 | 4 |
_aSkin Neoplasms _xgenetics |
| 700 | 1 | _aWilcox, William R | |
| 700 | 1 | _aKrejci, Pavel | |
| 773 | 0 |
_tHuman mutation _gvol. 33 _gno. 1 _gp. 29-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/humu.21636 _zAvailable from publisher's website |
| 999 |
_c21276047 _d21276047 |
||